Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-SARS-CoV-2 Antibody Response”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableUnknownNCT05079165
What this trial is testing

Covid Vaccination in Liver Transplantation

Who this might be right for
COVID-19
University Hospital, Strasbourg, France 300
Not applicableUnknownNCT05175989
What this trial is testing

SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

Who this might be right for
COVID-19 Vaccine
Rabin Medical Center 150
Not applicableEnded earlyNCT05142540
What this trial is testing

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Who this might be right for
Anti-SARS-CoV-2 Antibody Response
Medical University of Graz 140
Not applicableStudy completedNCT05490342
What this trial is testing

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Who this might be right for
SARS-CoV-2 VaccinationLiver Transplantation
University of Rome Tor Vergata 61
Not applicableLooking for participantsNCT04706390
What this trial is testing

Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination

Who this might be right for
Covid19
University of Bergen 2,500
Large-scale testing (Phase 3)Ended earlyNCT05074433
What this trial is testing

Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Who this might be right for
Immunocompromised
Regeneron Pharmaceuticals 66
Not applicableUnknownNCT04852835
What this trial is testing

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Who this might be right for
COVID-19 Vaccines
University Hospital, Strasbourg, France 800
Not applicableUnknownNCT04776005
What this trial is testing

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

Who this might be right for
Solid TumorHematologic MalignancyThoracic Cancer+2 more
Assistance Publique - Hôpitaux de Paris 500
Not applicableStudy completedNCT04734886
What this trial is testing

The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19

Who this might be right for
Covid19
Örebro University, Sweden 161
Testing effectiveness (Phase 2)Study completedNCT05077254
What this trial is testing

COVID Protection After Transplant-Immunosuppression Reduction

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05877508
What this trial is testing

Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

Who this might be right for
Long COVIDPost-Acute Sequela of COVID-19Post-Acute COVID-19
Michael Peluso, MD 36
Not applicableUnknownNCT05258708
What this trial is testing

COVID-19 Vaccine Reactogenicity and Immunogenicity

Who this might be right for
COVID-19Vaccine Immune ResponseVaccine Adverse Reaction
Korea University Guro Hospital 179
Testing effectiveness (Phase 2)Study completedNCT04969263
What this trial is testing

COVID-19 Protection After Transplant Pilot Study

Who this might be right for
Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 81